Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 44 entries
Sorted by: Best Match Show Resources per page
[No title available]

Maturitas

Georgousopoulou E, Panagiotakos DB, Mellor D, Naumovski N.
PMID: 28159056
Maturitas. 2017 Mar;97:21. doi: 10.1016/j.maturitas.2016.11.020. Epub 2016 Dec 08.

No abstract available.

Cite
Georgousopoulou E, Panagiotakos DB, Mellor D, et al. . Maturitas. 2016;97:21doi: 10.1016/j.maturitas.2016.11.020.
Georgousopoulou, E., Panagiotakos, D. B., Mellor, D., & Naumovski, N. (2017). . Maturitas, 9721. https://doi.org/10.1016/j.maturitas.2016.11.020
Georgousopoulou, Ekavi, et al. "." Maturitas vol. 97 (2017): 21. doi: https://doi.org/10.1016/j.maturitas.2016.11.020
Georgousopoulou E, Panagiotakos DB, Mellor D, Naumovski N. . Maturitas. 2017 Mar;97:21. doi: 10.1016/j.maturitas.2016.11.020. Epub 2016 Dec 08. PMID: 28159056.
Copy Download .nbib Format: NLM
The Effects of Dietary Polyphenols on Circulating Cardiovascular Disease Biomarkers and Iron Status: A Systematic Review.

Nutrition and metabolic insights

Speer H, D'Cunha NM, Botek M, McKune AJ, Sergi D, Georgousopoulou E, Mellor DD, Naumovski N.
PMID: 31673228
Nutr Metab Insights. 2019 Oct 21;12:1178638819882739. doi: 10.1177/1178638819882739. eCollection 2019.

The prevalence of cardiovascular disease (CVD) is rising worldwide, remaining the major cause of death in developed countries. Polyphenols have been shown to have cardioprotective properties; however, their impact on iron bioavailability and potential impact on other aspects of...

Cite
Speer H, D'Cunha NM, Botek M, et al. The Effects of Dietary Polyphenols on Circulating Cardiovascular Disease Biomarkers and Iron Status: A Systematic Review. Nutr Metab Insights. 2019;12:1178638819882739doi: 10.1177/1178638819882739.
Speer, H., D'Cunha, N. M., Botek, M., McKune, A. J., Sergi, D., Georgousopoulou, E., Mellor, D. D., & Naumovski, N. (2019). The Effects of Dietary Polyphenols on Circulating Cardiovascular Disease Biomarkers and Iron Status: A Systematic Review. Nutrition and metabolic insights, 121178638819882739. https://doi.org/10.1177/1178638819882739
Speer, Hollie, et al. "The Effects of Dietary Polyphenols on Circulating Cardiovascular Disease Biomarkers and Iron Status: A Systematic Review." Nutrition and metabolic insights vol. 12 (2019): 1178638819882739. doi: https://doi.org/10.1177/1178638819882739
Speer H, D'Cunha NM, Botek M, McKune AJ, Sergi D, Georgousopoulou E, Mellor DD, Naumovski N. The Effects of Dietary Polyphenols on Circulating Cardiovascular Disease Biomarkers and Iron Status: A Systematic Review. Nutr Metab Insights. 2019 Oct 21;12:1178638819882739. doi: 10.1177/1178638819882739. eCollection 2019. PMID: 31673228; PMCID: PMC6804354.
Copy Download .nbib Format: NLM
Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors.

Molecular cancer therapeutics

Gordon MS, Nemunaitis J, Barve M, Wainberg ZA, Hamilton EP, Ramanathan RK, Sledge GW, Yue H, Morgan-Lappe SE, Blaney M, Kasichayanula S, Motwani M, Wang L, Naumovski L, Strickler JH.
PMID: 34315767
Mol Cancer Ther. 2021 Oct;20(10):1988-1995. doi: 10.1158/1535-7163.MCT-20-0985. Epub 2021 Jul 26.

Dilpacimab (formerly ABT-165), a novel dual-variable domain immunoglobulin, targets both delta-like ligand 4 (DLL4) and VEGF pathways. Here, we present safety, pharmacokinetic (PK), pharmacodynamic (PD), and preliminary efficacy data from a phase I study (trial registration ID: NCT01946074) of...

Cite
Gordon MS, Nemunaitis J, Barve M, et al. Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors. Mol Cancer Ther. 2021;20(10):1988-1995doi: 10.1158/1535-7163.MCT-20-0985.
Gordon, M. S., Nemunaitis, J., Barve, M., Wainberg, Z. A., Hamilton, E. P., Ramanathan, R. K., Sledge, G. W., Yue, H., Morgan-Lappe, S. E., Blaney, M., Kasichayanula, S., Motwani, M., Wang, L., Naumovski, L., & Strickler, J. H. (2021). Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors. Molecular cancer therapeutics, 20(10), 1988-1995. https://doi.org/10.1158/1535-7163.MCT-20-0985
Gordon, Michael S, et al. "Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors." Molecular cancer therapeutics vol. 20,10 (2021): 1988-1995. doi: https://doi.org/10.1158/1535-7163.MCT-20-0985
Gordon MS, Nemunaitis J, Barve M, Wainberg ZA, Hamilton EP, Ramanathan RK, Sledge GW, Yue H, Morgan-Lappe SE, Blaney M, Kasichayanula S, Motwani M, Wang L, Naumovski L, Strickler JH. Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors. Mol Cancer Ther. 2021 Oct;20(10):1988-1995. doi: 10.1158/1535-7163.MCT-20-0985. Epub 2021 Jul 26. PMID: 34315767.
Copy Download .nbib Format: NLM
Sensory and Compositional Properties Affecting the Likeability of Commercially Available Australian Honeys.

Foods (Basel, Switzerland)

Hunter M, Kellett J, Toohey K, Naumovski N.
PMID: 34441619
Foods. 2021 Aug 09;10(8). doi: 10.3390/foods10081842.

Honey's composition and appearance is largely influenced by floral and geographic origins. Australian honeys are frequently sourced from supermarkets; however, properties associated with consumer preference and likeability remain relatively unknown. The aim of this study was to complete sensory...

Cite
Hunter M, Kellett J, Toohey K, et al. Sensory and Compositional Properties Affecting the Likeability of Commercially Available Australian Honeys. Foods. 2021;10(8)doi: 10.3390/foods10081842.
Hunter, M., Kellett, J., Toohey, K., & Naumovski, N. (2021). Sensory and Compositional Properties Affecting the Likeability of Commercially Available Australian Honeys. Foods (Basel, Switzerland), 10(8), . https://doi.org/10.3390/foods10081842
Hunter, Maddison, et al. "Sensory and Compositional Properties Affecting the Likeability of Commercially Available Australian Honeys." Foods (Basel, Switzerland) vol. 10,8 (2021). doi: https://doi.org/10.3390/foods10081842
Hunter M, Kellett J, Toohey K, Naumovski N. Sensory and Compositional Properties Affecting the Likeability of Commercially Available Australian Honeys. Foods. 2021 Aug 09;10(8). doi: 10.3390/foods10081842. PMID: 34441619; PMCID: PMC8393184.
Copy Download .nbib Format: NLM
Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet.

Frontiers in physiology

Sergi D, Naumovski N, Heilbronn LK, Abeywardena M, O'Callaghan N, Lionetti L, Luscombe-Marsh N.
PMID: 31130874
Front Physiol. 2019 May 03;10:532. doi: 10.3389/fphys.2019.00532. eCollection 2019.

Mitochondrial dysfunction has been implicated in the pathogenesis of insulin resistance, the hallmark of type 2 diabetes mellitus (T2DM). However, the cause-effect relationship remains to be fully elucidated. Compelling evidence suggests that boosting mitochondrial function may represent a valuable...

Cite
Sergi D, Naumovski N, Heilbronn LK, et al. Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet. Front Physiol. 2019;10:532doi: 10.3389/fphys.2019.00532.
Sergi, D., Naumovski, N., Heilbronn, L. K., Abeywardena, M., O'Callaghan, N., Lionetti, L., & Luscombe-Marsh, N. (2019). Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet. Frontiers in physiology, 10532. https://doi.org/10.3389/fphys.2019.00532
Sergi, Domenico, et al. "Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet." Frontiers in physiology vol. 10 (2019): 532. doi: https://doi.org/10.3389/fphys.2019.00532
Sergi D, Naumovski N, Heilbronn LK, Abeywardena M, O'Callaghan N, Lionetti L, Luscombe-Marsh N. Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet. Front Physiol. 2019 May 03;10:532. doi: 10.3389/fphys.2019.00532. eCollection 2019. PMID: 31130874; PMCID: PMC6510277.
Copy Download .nbib Format: NLM
402.1: Towards a GMP-Compliant Protocol for the Differentiation of Human Pluripotent Stem Cells to Beta-like Cells for the Treatment of Type 1 Diabetes.

Transplantation

Rajaei B, Roelofsen AL, Shokrollahi E, Brinkhof B, Naumovska E, van der Sluis RJ, Nieveen M, Engelse M, de Koning E, Carlotti F.
PMID: 34908335
Transplantation. 2021 Dec 01;105(12):S26. doi: 10.1097/01.tp.0000804432.75585.bf.

No abstract available.

Cite
Rajaei B, Roelofsen AL, Shokrollahi E, et al. 402.1: Towards a GMP-Compliant Protocol for the Differentiation of Human Pluripotent Stem Cells to Beta-like Cells for the Treatment of Type 1 Diabetes. Transplantation. 2021;105(12):S26doi: 10.1097/01.tp.0000804432.75585.bf.
Rajaei, B., Roelofsen, A. L., Shokrollahi, E., Brinkhof, B., Naumovska, E., van der Sluis, R. J., Nieveen, M., Engelse, M., de Koning, E., & Carlotti, F. (2021). 402.1: Towards a GMP-Compliant Protocol for the Differentiation of Human Pluripotent Stem Cells to Beta-like Cells for the Treatment of Type 1 Diabetes. Transplantation, 105(12), S26. https://doi.org/10.1097/01.tp.0000804432.75585.bf
Rajaei, Bahareh, et al. "402.1: Towards a GMP-Compliant Protocol for the Differentiation of Human Pluripotent Stem Cells to Beta-like Cells for the Treatment of Type 1 Diabetes." Transplantation vol. 105,12 (2021): S26. doi: https://doi.org/10.1097/01.tp.0000804432.75585.bf
Rajaei B, Roelofsen AL, Shokrollahi E, Brinkhof B, Naumovska E, van der Sluis RJ, Nieveen M, Engelse M, de Koning E, Carlotti F. 402.1: Towards a GMP-Compliant Protocol for the Differentiation of Human Pluripotent Stem Cells to Beta-like Cells for the Treatment of Type 1 Diabetes. Transplantation. 2021 Dec 01;105(12):S26. doi: 10.1097/01.tp.0000804432.75585.bf. PMID: 34908335.
Copy Download .nbib Format: NLM
402.1: Towards a GMP-Compliant Protocol for the Differentiation of Human Pluripotent Stem Cells to Beta-like Cells for the Treatment of Type 1 Diabetes.

Transplantation

Rajaei B, Roelofsen AL, Shokrollahi E, Brinkhof B, Naumovska E, van der Sluis RJ, Nieveen M, Engelse M, de Koning E, Carlotti F.
PMID: 34908335
Transplantation. 2021 Dec 01;105(12):S26. doi: 10.1097/01.tp.0000804432.75585.bf.

No abstract available.

Cite
Rajaei B, Roelofsen AL, Shokrollahi E, et al. 402.1: Towards a GMP-Compliant Protocol for the Differentiation of Human Pluripotent Stem Cells to Beta-like Cells for the Treatment of Type 1 Diabetes. Transplantation. 2021;105(12):S26doi: 10.1097/01.tp.0000804432.75585.bf.
Rajaei, B., Roelofsen, A. L., Shokrollahi, E., Brinkhof, B., Naumovska, E., van der Sluis, R. J., Nieveen, M., Engelse, M., de Koning, E., & Carlotti, F. (2021). 402.1: Towards a GMP-Compliant Protocol for the Differentiation of Human Pluripotent Stem Cells to Beta-like Cells for the Treatment of Type 1 Diabetes. Transplantation, 105(12), S26. https://doi.org/10.1097/01.tp.0000804432.75585.bf
Rajaei, Bahareh, et al. "402.1: Towards a GMP-Compliant Protocol for the Differentiation of Human Pluripotent Stem Cells to Beta-like Cells for the Treatment of Type 1 Diabetes." Transplantation vol. 105,12 (2021): S26. doi: https://doi.org/10.1097/01.tp.0000804432.75585.bf
Rajaei B, Roelofsen AL, Shokrollahi E, Brinkhof B, Naumovska E, van der Sluis RJ, Nieveen M, Engelse M, de Koning E, Carlotti F. 402.1: Towards a GMP-Compliant Protocol for the Differentiation of Human Pluripotent Stem Cells to Beta-like Cells for the Treatment of Type 1 Diabetes. Transplantation. 2021 Dec 01;105(12):S26. doi: 10.1097/01.tp.0000804432.75585.bf. PMID: 34908335.
Copy Download .nbib Format: NLM
Food Habits of Older Australians Living Alone in the Australian Capital Territory.

Geriatrics (Basel, Switzerland)

Low E, Kellett J, Bacon R, Naumovski N.
PMID: 32962146
Geriatrics (Basel). 2020 Sep 18;5(3). doi: 10.3390/geriatrics5030055.

The link between adequate nutrition and quality of life for older persons is well established. With the proportion of older adults increasing, policy regarding support and care for the ageing has shifted emphasis to keeping older adults in their...

Cite
Low E, Kellett J, Bacon R, et al. Food Habits of Older Australians Living Alone in the Australian Capital Territory. Geriatrics (Basel). 2020;5(3)doi: 10.3390/geriatrics5030055.
Low, E., Kellett, J., Bacon, R., & Naumovski, N. (2020). Food Habits of Older Australians Living Alone in the Australian Capital Territory. Geriatrics (Basel, Switzerland), 5(3), . https://doi.org/10.3390/geriatrics5030055
Low, Elizabeth, et al. "Food Habits of Older Australians Living Alone in the Australian Capital Territory." Geriatrics (Basel, Switzerland) vol. 5,3 (2020). doi: https://doi.org/10.3390/geriatrics5030055
Low E, Kellett J, Bacon R, Naumovski N. Food Habits of Older Australians Living Alone in the Australian Capital Territory. Geriatrics (Basel). 2020 Sep 18;5(3). doi: 10.3390/geriatrics5030055. PMID: 32962146; PMCID: PMC7555807.
Copy Download .nbib Format: NLM
Accidental injection of succinylcholine into epidural space as a test dose.

Saudi journal of anaesthesia

Toleska M, Naumovski F, Dimitrovski A.
PMID: 32317884
Saudi J Anaesth. 2020 Apr-Jun;14(2):238-240. doi: 10.4103/sja.SJA_646_19. Epub 2020 Mar 05.

Inadvertent injection of nonepidural drugs into the epidural space is a rare situation, which is under-reported, and can lead to serious complications, such as cardiovascular and respiratory complications, paraplegia, or quadriplegia, and can worsen the patients' outcome from surgery....

Cite
Toleska M, Naumovski F, Dimitrovski A. Accidental injection of succinylcholine into epidural space as a test dose. Saudi J Anaesth. 2020;14(2):238-240doi: 10.4103/sja.SJA_646_19.
Toleska, M., Naumovski, F., & Dimitrovski, A. (2020). Accidental injection of succinylcholine into epidural space as a test dose. Saudi journal of anaesthesia, 14(2), 238-240. https://doi.org/10.4103/sja.SJA_646_19
Toleska, Marija, et al. "Accidental injection of succinylcholine into epidural space as a test dose." Saudi journal of anaesthesia vol. 14,2 (2020): 238-240. doi: https://doi.org/10.4103/sja.SJA_646_19
Toleska M, Naumovski F, Dimitrovski A. Accidental injection of succinylcholine into epidural space as a test dose. Saudi J Anaesth. 2020 Apr-Jun;14(2):238-240. doi: 10.4103/sja.SJA_646_19. Epub 2020 Mar 05. PMID: 32317884; PMCID: PMC7164469.
Copy Download .nbib Format: NLM
Measuring Heart Rate Variability Using Commercially Available Devices in Healthy Children: A Validity and Reliability Study.

European journal of investigation in health, psychology and education

Speer KE, Semple S, Naumovski N, McKune AJ.
PMID: 34542492
Eur J Investig Health Psychol Educ. 2020 Jan 10;10(1):390-404. doi: 10.3390/ejihpe10010029.

Heart rate variability (HRV) is an accepted method for determining autonomic nervous system activity and cardiovascular risk in various populations. This study assessed the validity and reliability of a commercially available finger photoplethysmography (PPG) system for measuring pediatric HRV...

Cite
Speer KE, Semple S, Naumovski N, et al. Measuring Heart Rate Variability Using Commercially Available Devices in Healthy Children: A Validity and Reliability Study. Eur J Investig Health Psychol Educ. 2020;10(1):390-404doi: 10.3390/ejihpe10010029.
Speer, K. E., Semple, S., Naumovski, N., & McKune, A. J. (2020). Measuring Heart Rate Variability Using Commercially Available Devices in Healthy Children: A Validity and Reliability Study. European journal of investigation in health, psychology and education, 10(1), 390-404. https://doi.org/10.3390/ejihpe10010029
Speer, Kathryn E, et al. "Measuring Heart Rate Variability Using Commercially Available Devices in Healthy Children: A Validity and Reliability Study." European journal of investigation in health, psychology and education vol. 10,1 (2020): 390-404. doi: https://doi.org/10.3390/ejihpe10010029
Speer KE, Semple S, Naumovski N, McKune AJ. Measuring Heart Rate Variability Using Commercially Available Devices in Healthy Children: A Validity and Reliability Study. Eur J Investig Health Psychol Educ. 2020 Jan 10;10(1):390-404. doi: 10.3390/ejihpe10010029. PMID: 34542492; PMCID: PMC8314243.
Copy Download .nbib Format: NLM
Acute severe poisoning with disinfectant in senior aged patient-case report and overview of literature considering age influence on treatment decision in alcohol-based intoxications.

SAGE open medical case reports

Pereska Z, Simonovska N, Babulovska A, Berat-Huseini A, Naumoski K, Kostadinoski K.
PMID: 34567557
SAGE Open Med Case Rep. 2021 Sep 19;9:2050313X211047717. doi: 10.1177/2050313X211047717. eCollection 2021.

We present our experiences in the first case of severe suicidal poisoning with 70% ethanol-disinfectant in North Macedonia, in an elderly patient with immunocompromising comorbidities. A 66-year-old unconscious woman was admitted at our clinic, with a history of seropositive...

Cite
Pereska Z, Simonovska N, Babulovska A, et al. Acute severe poisoning with disinfectant in senior aged patient-case report and overview of literature considering age influence on treatment decision in alcohol-based intoxications. SAGE Open Med Case Rep. 2021;9:2050313X211047717doi: 10.1177/2050313X211047717.
Pereska, Z., Simonovska, N., Babulovska, A., Berat-Huseini, A., Naumoski, K., & Kostadinoski, K. (2021). Acute severe poisoning with disinfectant in senior aged patient-case report and overview of literature considering age influence on treatment decision in alcohol-based intoxications. SAGE open medical case reports, 92050313X211047717. https://doi.org/10.1177/2050313X211047717
Pereska, Zanina, et al. "Acute severe poisoning with disinfectant in senior aged patient-case report and overview of literature considering age influence on treatment decision in alcohol-based intoxications." SAGE open medical case reports vol. 9 (2021): 2050313X211047717. doi: https://doi.org/10.1177/2050313X211047717
Pereska Z, Simonovska N, Babulovska A, Berat-Huseini A, Naumoski K, Kostadinoski K. Acute severe poisoning with disinfectant in senior aged patient-case report and overview of literature considering age influence on treatment decision in alcohol-based intoxications. SAGE Open Med Case Rep. 2021 Sep 19;9:2050313X211047717. doi: 10.1177/2050313X211047717. eCollection 2021. PMID: 34567557; PMCID: PMC8461117.
Copy Download .nbib Format: NLM
First-in-Human Phase I Study of ABBV-085, an Antibody-Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research

Demetri GD, Luke JJ, Hollebecque A, Powderly JD, Spira AI, Subbiah V, Naumovski L, Chen C, Fang H, Lai DW, Yue H, Polepally AR, Purcell JW, Robinson R, Sharma P, Allison JP, Tolcher A, Villalobos VM.
PMID: 33820780
Clin Cancer Res. 2021 Jul 01;27(13):3556-3566. doi: 10.1158/1078-0432.CCR-20-4513. Epub 2021 Apr 05.

PURPOSE: Leucine-rich repeat containing 15 (LRRC15) is expressed on stromal fibroblasts in the tumor microenvironment of multiple solid tumor types and may represent an interesting target for therapy, particularly in patients with sarcomas where LRRC15 is also expressed by...

Cite
Demetri GD, Luke JJ, Hollebecque A, et al. First-in-Human Phase I Study of ABBV-085, an Antibody-Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors. Clin Cancer Res. 2021;27(13):3556-3566doi: 10.1158/1078-0432.CCR-20-4513.
Demetri, G. D., Luke, J. J., Hollebecque, A., Powderly, J. D., Spira, A. I., Subbiah, V., Naumovski, L., Chen, C., Fang, H., Lai, D. W., Yue, H., Polepally, A. R., Purcell, J. W., Robinson, R., Sharma, P., Allison, J. P., Tolcher, A., & Villalobos, V. M. (2021). First-in-Human Phase I Study of ABBV-085, an Antibody-Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(13), 3556-3566. https://doi.org/10.1158/1078-0432.CCR-20-4513
Demetri, George D, et al. "First-in-Human Phase I Study of ABBV-085, an Antibody-Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,13 (2021): 3556-3566. doi: https://doi.org/10.1158/1078-0432.CCR-20-4513
Demetri GD, Luke JJ, Hollebecque A, Powderly JD, Spira AI, Subbiah V, Naumovski L, Chen C, Fang H, Lai DW, Yue H, Polepally AR, Purcell JW, Robinson R, Sharma P, Allison JP, Tolcher A, Villalobos VM. First-in-Human Phase I Study of ABBV-085, an Antibody-Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors. Clin Cancer Res. 2021 Jul 01;27(13):3556-3566. doi: 10.1158/1078-0432.CCR-20-4513. Epub 2021 Apr 05. PMID: 33820780.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 44 entries